tiprankstipranks
Trending News
More News >
Argent Biopharma Ltd (AU:RGT)
OTHER OTC:RGT
Australian Market

Argent Biopharma (RGT) Financial Statements

Compare
6 Followers

Argent Biopharma Financial Overview

Argent Biopharma's market cap is currently AU$5.42M. The company's EPS TTM is AU$-0.079; its P/E ratio is -0.20; Argent Biopharma is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 583.45KAU$ 891.08KAU$ 3.39MAU$ 4.73M
Gross ProfitAU$ 446.32KAU$ 203.70KAU$ 1.45MAU$ 1.81M
Operating IncomeAU$ -15.44MAU$ -18.26MAU$ -15.60MAU$ -14.26M
EBITDAAU$ -17.00MAU$ -15.77MAU$ -20.04MAU$ -16.70M
Net IncomeAU$ -17.84MAU$ -17.53MAU$ -20.82MAU$ -16.77M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 1.02MAU$ 702.87KAU$ 239.82KAU$ 1.79M
Total AssetsAU$ 2.47MAU$ 10.79MAU$ 9.88MAU$ 23.55M
Total DebtAU$ 8.29MAU$ 1.04MAU$ 575.14KAU$ 4.39M
Net DebtAU$ 7.26MAU$ 341.85KAU$ 335.32KAU$ 2.61M
Total LiabilitiesAU$ 11.10MAU$ 16.61MAU$ 18.02MAU$ 13.66M
Stockholders' EquityAU$ -8.63MAU$ -5.15MAU$ -7.51MAU$ 11.23M
Cash Flow
Free Cash FlowAU$ -9.28MAU$ -14.40MAU$ -11.26MAU$ -14.85M
Operating Cash FlowAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Investing Cash FlowAU$ 208.83KAU$ -140.12KAU$ 51.75KAU$ -2.44M
Financing Cash FlowAU$ 9.39MAU$ 14.87MAU$ 9.31MAU$ 9.74M
Currency in AUD

Argent Biopharma Earnings and Revenue History

Argent Biopharma Debt to Assets

Argent Biopharma Cash Flow

Argent Biopharma Forecast EPS vs Actual EPS